Monday, September 22, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Barclays Analyst Brandon Oglenski Upgrades XPO Rating to Overweight with New Price Target of 145

Elaine Mendonca by Elaine Mendonca
March 11, 2024
in Breaking News
0
Finance_ Trading ratings today (2)
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

Barclays analyst Brandon Oglenski remains bullish on XPO (NYSE:XPO) with an Overweight rating and a new price target of $145, up from $125. The increased target signifies Oglenski’s optimistic view on the company’s future prospects as of March 11, 2024.

XPO Stock Price Drops 4.33% on March 11, 2024: Investors Optimistic About Future Performance

On March 11, 2024, XPO stock experienced a significant drop in price, decreasing by $5.54 or 4.33% since the market last closed. This decline brought the stock price down to $122.43. Despite the drop in price during regular trading hours, XPO stock showed some signs of recovery in pre-market trading, rising by $0.07. This slight increase may indicate that investors are feeling more optimistic about the stock’s future performance. Investors should conduct thorough research and consider their own financial goals before making any investment decisions. Overall, the performance of XPO stock on March 11, 2024, highlights the volatility of the market and the importance of staying informed and vigilant as an investor. Keep an eye on future developments to see how XPO stock continues to perform in the coming days and weeks.

XPO Logistics Financial Performance Decline Raises Concerns: Whats Next?

XPO Logistics has been facing challenges in its financial performance recently. On March 11, 2024, the company reported total revenue of $7.74 billion for the past year, which remained flat compared to the previous year. The total revenue for the fourth quarter of the year was $1.94 billion, showing no growth compared to the previous quarter.

One concerning aspect is the decline in net income. The company reported a net income of $189.00 million for the past year, a 19.92% decrease from the previous year. In the fourth quarter, the net income further decreased to $58.00 million, marking a 32.56% decline from the previous quarter.

Earnings per share (EPS) also saw a significant decrease. The company reported an EPS of $1.60 for the past year, representing a 21.27% decrease from the previous year. In the fourth quarter, the EPS further declined to $0.48, marking a 31.53% decrease from the previous quarter.

These financial indicators raise concerns about XPO Logistics’ ability to maintain profitability and growth in the future. It will be important for XPO to address the factors contributing to these declines and implement strategies to improve its financial performance in order to regain investor confidence.

Tags: XPO
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

Sam Edelmans SpringSummer 2024 Campaign Featuring Kylie Jenner Celebrating 20 Years of Style

Cleanest energy and ev

Uranium Energy Corp Reports Decline in Quarterly Financial Performance

Lexicon Pharmaceuticals to Resubmit NDA for Sotagliflozin as Complement to Insulin Treatment for Type 1 Diabetes

Recommended

Emergent BioSolutions Stock

A Tale of Two Realities: Emergent BioSolutions’ Social Mission and Financial Strain

4 weeks ago
Food Retailers Stock Bull Market

JP Morgan Analyst Maintains Neutral Rating on Tyson Foods with Revised Price Target

2 years ago
MMM stock news

Bearish Sentiment Surrounds Air Lease NYSE AL Trading

2 years ago
QuantumScape Stock

QuantumScape Leadership Executes Major Stock Sales, Raising Investor Concerns

5 days ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

AAPL Adobe Alibaba Alphabet Amazon AMD AMZN Apple ASML BA BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv Hims & Hers IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Opendoor Oracle Oxford Lane Capital Palantir PayPal Pepsi Red Cat Robinhood Rocket Lab USA Salesforce Strategy Tesla TSLA Unitedhealth Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

Leadership Crisis at Nestlé Sparks Investor Concerns

Standex Shares Plunge Amid Technical Warnings and Insider Selling

Navigating Credit Headwinds: Synchrony’s Strategic Expansion Amid Sector Challenges

Tech Sector Surge: AI and Cloud Computing Fuel Vanguard ETF’s Record Run

Trending

Pfizer Stock
Healthcare

Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena

by Dieter Jaworski
September 22, 2025
0

In a move signaling its serious intent to capture a share of the lucrative anti-obesity drug market,...

Nike Stock

Nike Shares Face Critical Earnings Test

September 22, 2025
Tutor Perini Stock

Insider Sales at Tutor Perini Coincide with Stock Peak

September 22, 2025
Ubiquiti Stock

Ubiquiti Shares Reach New Heights on Product Expansion Momentum

September 22, 2025
BioNTech Stock

BioNTech’s Strategic Pivot: From Pandemic Success to Oncology Innovation

September 22, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Pfizer’s Strategic Gambit: A $7.3 Billion Entry into the Weight-Loss Arena
  • Nike Shares Face Critical Earnings Test
  • Insider Sales at Tutor Perini Coincide with Stock Peak

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com